Herantis Pharma Certified Adviser change

Herantis Pharma Certified Adviser change

Herantis Pharma Plc
Company release 1 July 2015 at 10:00 am

The shares of Herantis Pharma Plc are listed for trading on Nasdaq Helsinki First North Finland, which requires the nominating of a Certified Adviser. Effective 1 July 2015, the Certified Adviser to Herantis Pharma Plc is UB Securities Ltd. The Certified Adviser to Herantis Pharma until 30 June 2015 was UB Capital Ltd.

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 2538 0254

About Herantis Pharma Plc

Herantis Pharma Plc is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson’s disease, and secondary lymphedema. We believe our drugs are the first or best in their class and have the potential to change treatment strategies of diseases. The shares of Herantis Pharma Plc are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange.